Bioorganic and Medicinal Chemistry Letters p. 3029 - 3034 (1996)
Update date:2022-07-29
Topics:
Veenstra, Siem J.
Hauser, Kathleen
Schilling, Walter
Betschart, Claudia
Ofner, Silvio
CGP 49823 is a potent NK1 antagonist which is centrally active after oral administration. The SAR of the C-2 substituent was investigated with respect to the affinity to the NK1 receptor. A practical synthesis of CGP 49823, suitable for scale-up, was developed. The key-step, a tandem acyliminium ion cyclization/Ritter reaction, gave trans-2-benzyl-4-acetamido-piperidines with high diastereoselectivity.
View MoreSuzhou Chiral Pharmaceuticals Co., Ltd.
Contact:86-0512-63197058
Address:Building A, No. 2358, Chang'an Road, Wujiang Science Park
ChangZhou XiaQing Chemical Co., Ltd.
Contact:+86-519-88721665
Address:3# Hengluo Road, Henglin Town, Changzhou City, Jiangsu Province，China
Contact:0510-85393305
Address:1619 Huishan Avenue, Huishan District, Wuxi,
Zhuhai Rundu Pharmaceutical co.,Ltd
Contact:+86-756-7630755
Address:No.6,North Airport Road,Sanzao Town,Jinwan District
Suzhou Kangrun Pharmaceutical, Inc
Contact:86-512-63912376，63913329
Address:Building 2, No. 2358 ,Chang'an Rd, Wujiang Economic Development Zone Pioneering park, china
Doi:10.1021/jo961781i
(1997)Doi:10.1016/S0960-894X(97)00008-5
(1997)Doi:10.1002/jhet.5570330626
(1996)Doi:10.1021/ja01077a028
(1964)Doi:10.1248/cpb.45.53
(1997)Doi:10.1021/ja01101a038
(1953)
